Clinical spectrum in a family with tropomyosin-mediated hypertrophic cardiomyopathy and sudden death in childhood

Pediatric Cardiology

Volumn 32, Issue 2, 2011, Pages 215-220

  Makhoul, Majd ^a   Ackerman, Michael J ^b   Atkins, Dianne L ^a   Law, Ian H ^a  

^a UNIVERSITY OF IOWA CHILDREN S HOSPITAL   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Hypertrophic cardiomyopathy; Implantable cardioverter defibrillator; Sudden cardiac death

Indexed keywords

ALPHA TROPOMYOSIN; AMIODARONE; BISOPROLOL;

ADOLESCENT; ADULT; ARTICLE; AUTOPSY; CASE REPORT; CHILD; DEFIBRILLATOR; DISEASE COURSE; DISEASE SEVERITY; DOSE RESPONSE; DRUG DOSE INCREASE; FEMALE; HEART ARRHYTHMIA; HEART CATHETERIZATION; HEART DEATH; HEART LEFT VENTRICLE HYPERTROPHY; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MALE; MISSENSE MUTATION; MITRAL VALVE REGURGITATION; PATIENT COMPLIANCE; PEDIGREE ANALYSIS; SCHOOL CHILD; SUDDEN DEATH;

ADOLESCENT; ARRHYTHMIAS, CARDIAC; AUTOPSY; CARDIOMYOPATHY, HYPERTROPHIC; CHILD; CHILD WELFARE; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FATAL OUTCOME; FEMALE; GENOTYPE; HUMANS; MALE; PHENOTYPE; RISK FACTORS; TROPOMYOSIN; YOUNG ADULT;

EID: 79952311961     PISSN: 01720643     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00246-010-9843-1     Document Type: Article

References (17)

1. BJ Maron 2010 Contemporary insights and strategies for risk stratification and prevention of sudden death in hypertrophic cardiomyopathy Circulation 121 445 456 10.1161/CIRCULATIONAHA.109.878579 20100987
2. BJ Maron 2002 Hypertrophic cardiomyopathy: a systematic review JAMA 287 1308 1320 10.1001/jama.287.10.1308 11886323 (Pubitemid 34250486)
3. BJ Maron WJ McKenna GK Danielson LJ Kappenberger HJ Kuhn CE Seidman, et al. 2003 American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus documents and the European Society of Cardiology Committee for Practice Guidelines J Am Coll Cardiol 42 1687 1713 10.1016/S0735-1097(03)00941-0 14607462 (Pubitemid 37383745)
4. F Cecchi I Olivotto A Montereggi G Santoro A Dolara BJ Maron 1995 Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population Am Coll Cardiol 26 1529 1536 1:STN:280: DyaK28%2FmtV2msg%3D%3D 10.1016/0735-1097(95)00353-3
5. BJ Maron SA Casey LC Poliac TE Gohman AK Almquist DM Aeppli 1999 Clinical course of hypertrophic cardiomyopathy in a regional United States cohort JAMA 281 650 655 1:STN:280:DyaK1M7ltFGrtA%3D%3D 10.1001/jama.281.7.650 10029128 (Pubitemid 29098067)
6. SL Van Driest ML Will DL Atkins MJ Ackerman 2002 A novel TPM1 mutation in a family with hypertrophic cardiomyopathy and sudden cardiac death in childhood Am J Cardiol 90 1123 1127 10.1016/S0002-9149(02)02780-7 12423715 (Pubitemid 35335603)
7. BJ Maron I Olivotto P Spirito SA Casey P Bellone TG Gohman, et al. 2000 Epidemiology of hypertrophic cardiomyopathy-related death: Revisited in a large non-referral-based patient population Circulation 102 858 864 1:STN:280:DC%2BD3cvhvFWhuw%3D%3D 10952953
8. Australian national FHCM database. http://www.angis.org.au/Databases/ Heart/heartbreak.html. Accessed 5 February 2010
9. Gould SE (1960) Pathology of the heart, 2nd edn. Charles C Thomas, Springfield, pp 1063-1065
10. CA Gurnett DL Atkins 2000 Home use of a biphasic waveform automated external defibrillator in a high-risk 3-year-old child Am J Cardiol 86 1051 1053 1:STN:280:DC%2BD3M%2FptVGltA%3D%3D 10.1016/S0002-9149(00)01151-6 11053729
11. LC Poliac ME Barron BJ Maron 2006 Hypertrophic cardiomyopathy Anesthesiology 104 183 192 10.1097/00000542-200601000-00025 16394705
12. WJ McKenna ER Behr 2002 Hypertrophic cardiomyopathy: management, risk stratification, and prevention of sudden death Heart 87 169 176 10.1136/heart.87.2.169 11796562 (Pubitemid 34098386)
13. I Christiaans RH Lekanne dit Deprez IM Van Langen AA Wilde 2009 Ventricular fibrillation in MYH7-related hypertrophic cardiomyopathy before onset of ventricular hypertrophy Heart Rhythm 6 1366 1369 10.1016/j.hrthm.2009. 04.029 19539541
14. JA Decker JW Rossano E O'Brian Smith B Cannon SK Clunie C Gates, et al. 2009 Risk factors and mode of death in isolated hypertrophic cardiomyopathy in children Am Coll Cardiol 54 250 254 10.1016/j.jacc.2009.03.051
15. SC Menon MJ Ackerman F Cetta PW O'Leary BW Eidem 2008 Significance of left atrial volume in patients <20 years of age with hypertrophic cardiomyopathy Am J Cardiol 102 1390 1393 10.1016/j.amjcard.2008.07.027 18993161
16. MJ Perkins SL Van Driest EG Ellsworth ML Will BJ Gersh SR Ommen, et al. 2005 Gene-specific modifying effects of pro-LVH polymorphisms involving the renin-angiotensin-aldosterone system among 389 unrelated patients with hypertrophic cardiomyopathy Eur Heart J 26 2457 2462 1:CAS:528: DC%2BD2MXhtlSisbjI 10.1093/eurheartj/ehi438 16087648 (Pubitemid 41552976)
17. MJ Ackerman SL Van Driest SR Ommen ML Will RA Nishimura AJ Tajik, et al. 2002 Prevalence and age-dependence of malignant mutations in the beta-myosin heavy chain and troponin T genes in hypertrophic cardiomyopathy: a comprehensive outpatient perspective Am Coll Cardiol 39 2042 2048 1:CAS:528: DC%2BD38Xlt1Kisb8%3D 10.1016/S0735-1097(02)01900-9 (Pubitemid 34628288)